Analyst picks & changes

Analyst picks & changes

Company Bank Analyst Coverage Opinion Wk chg 5/9 cls
Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) Cowen Nicholas Bishop Downgrade Market perform (from outperform) -25% $32.62
Bishop also lowered his target to $36 from $85 after Aegerion reported 1Q14 sales of Juxtapid

Read the full 579 word article

How to gain access

Continue reading with a
two-week free trial.